Carboprost Tromethamine Injection, Solution
Product Images NDC 55150-459

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carboprost Tromethamine (NDC 55150-459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carboprost-fig1 (Carboprost Fig1)

Label for Carboprost Tromethamine Injection, USP, 250 mcg per mL, in a 1 mL single-dose vial. The drug is indicated for intramuscular use only. It is manufactured in India for Eugia US LLC, with storage instructions to refrigerate between 2° to 8°C (36° to 46°F). The label includes the NDC 55150-459-01 and advises to see accompanying prescribing information for dosage and use.*

FDA Label Image

Carboprost-fig2 (Carboprost Fig2)

Packaging label for Carboprost Tromethamine Injection, USP 250 mcg per mL, an intramuscular injection solution. The label indicates a package containing 10 single-dose 1 mL vials. Distributed by Eugia US LLC, the label includes storage instructions and a barcode.*

FDA Label Image

Carboprost-str (Carboprost Str)

Chemical structure of Carboprost Tromethamine, depicted as a molecular diagram showing its chemical composition and arrangement, including a complex organic molecular structure with functional groups and a tromethamine moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.